Immediate Impact
5 by Nobel laureates 2 from Science/Nature 59 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Preeti Narayan being referenced
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
2021
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Preeti Narayan | 76 | 232 | 88 | 153 | 105 | 16 | 464 | |
| Philippe C. Bishop | 98 | 161 | 48 | 108 | 66 | 17 | 490 | |
| Ana T. Nunes | 67 | 257 | 35 | 114 | 79 | 18 | 425 | |
| Maurizia Giai | 99 | 134 | 36 | 274 | 74 | 13 | 564 | |
| Nicole Kelbick | 94 | 256 | 21 | 157 | 63 | 9 | 511 | |
| Luigi Pio Guerrera | 35 | 179 | 56 | 118 | 33 | 20 | 526 | |
| Akimitsu Hiraki | 58 | 244 | 96 | 179 | 91 | 20 | 513 | |
| Kathrin Glatz | 115 | 330 | 128 | 97 | 83 | 12 | 572 | |
| Gert Jan Fleuren | 71 | 114 | 64 | 108 | 91 | 16 | 457 | |
| G Kamińska | 47 | 137 | 29 | 264 | 88 | 21 | 509 | |
| T. Megha | 66 | 212 | 57 | 156 | 75 | 16 | 496 |
All Works
Login with ORCID to disown or claim papers
Loading papers...